ISTURISA 10 MG Israel - English - Ministry of Health

isturisa 10 mg

medison pharma ltd - osilodrostat as phosphate - film coated tablets - osilodrostat as phosphate 10 mg - osilodrostat - isturisa is indicated for the treatment of endogenous cushing’s syndrome in adult patients for whom surgery is not an option or has not been curative

ISTURISA 5 MG Israel - English - Ministry of Health

isturisa 5 mg

medison pharma ltd - osilodrostat as phosphate - film coated tablets - osilodrostat as phosphate 5 mg - osilodrostat - isturisa is indicated for the treatment of endogenous cushing’s syndrome in adult patients for whom surgery is not an option or has not been curative.

KETOCONAZOLE HRA 200 MG Israel - English - Ministry of Health

ketoconazole hra 200 mg

cts ltd - ketoconazole - tablets - ketoconazole 200 mg - ketoconazole - treatment of endogenous cushing's syndrome in adults and adolescents above the age of 12 years.

KETOCONAZOLE HRA 200 MG Israel - English - Ministry of Health

ketoconazole hra 200 mg

cts ltd - ketoconazole - tablets - ketoconazole 200 mg - ketoconazole - treatment of endogenous cushing's syndrome in adults and adolescents above the age of 12 years.

SIGNIFOR LAR 20 mg INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

signifor lar 20 mg injection

key oncologics (pty) ltd - injection - see ingredients - each vial contains pasireotide pamoate equivalent to pasireotide 20,0 mg

SIGNIFOR LAR 40 mg INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

signifor lar 40 mg injection

key oncologics (pty) ltd - injection - see ingredients - each vial contains pasireotide pamoate equivalent to pasireotide 40,0 mg

SIGNIFOR LAR 60 mg INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

signifor lar 60 mg injection

key oncologics (pty) ltd - injection - see ingredients - each vial contains pasireotide pamoate equivalent to pasireotide 60,0 mg

SIGNIFOR 0,3 mg /ml Injection South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

signifor 0,3 mg /ml injection

novartis south africa (pty) ltd - injection - each ampoule contains pasireotide diaspartate equivalent to pasireotide 0,3 mg

SIGNIFOR 0,6 mg /ml Injection South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

signifor 0,6 mg /ml injection

novartis south africa (pty) ltd - injection - each ampoule contains pasireotide diaspartate equivalent to pasireotide 0,6 mg